Re: This Covid 19 possibility has
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 09:48AM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 09:31AM
|
Re: Trying to be realistic here
|
9
|
Resverlogix Corp.
|
Mar 25, 2020 10:49AM
|
Re: Epigenetics and Coronavirus
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 11:47AM
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 07:54PM
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 03:59PM
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
1
|
Resverlogix Corp.
|
Mar 15, 2020 03:30PM
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
5
|
Resverlogix Corp.
|
Mar 15, 2020 03:01PM
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
5
|
Resverlogix Corp.
|
Mar 15, 2020 12:24PM
|
Re: 47 Taken out by Gilead for $4.9 billion
|
3
|
Resverlogix Corp.
|
Mar 05, 2020 08:12AM
|
Re: 47 Taken out by Gilead for $4.9 billion
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 08:06AM
|
Re: Where is the bounce?
|
3
|
Resverlogix Corp.
|
Mar 04, 2020 01:39PM
|
Re: Where is the bounce?
|
5
|
Resverlogix Corp.
|
Mar 04, 2020 11:31AM
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Mar 03, 2020 10:18AM
|
Re: Entresto VS Apabetalone
|
3
|
Resverlogix Corp.
|
Mar 02, 2020 04:27PM
|
Re: Nice problem to have....
|
3
|
Resverlogix Corp.
|
Mar 02, 2020 11:27AM
|
Re: Nice problem to have....
|
5
|
Resverlogix Corp.
|
Mar 02, 2020 11:23AM
|
Re: Nice problem to have....
|
4
|
Resverlogix Corp.
|
Mar 02, 2020 09:37AM
|
Re: Symptoms, causes, and treatment of chronic kidney disease
|
6
|
Resverlogix Corp.
|
Mar 02, 2020 09:23AM
|
Re: The canadian comparison
|
3
|
Resverlogix Corp.
|
Mar 01, 2020 02:59AM
|